#RECOVERYtrial

@DrAbdulRazak_MD @EBNEO Congratulations @DTrevisanuto and team for this excellent review! Great resource for all Paeds folks. Most Helpful too for #RECOVERYtrial team neo @SaulFaust @DrCGale @docpaulfleming @EdJuszczak @Oxford_NDPH @NPEU_CTU #developingandapplyingresearch

How did the #RECOVERYtrial use smart trial design and tap into existing health datasets to become the most successful trial in #COVID19 to date? 👉 https://t.co/Xjgc4gr1mC @HDR_UK @NHSDigital #NHSDigitrials @OxfordBRC https://t.co/XpudWo0BAV

Quoted @ABsteward

🔥Breaking news🔥 RECOVERY COVID-19 phase 3 trial to evaluate @Regeneron REGN-COV2 investigational antibody cocktail in the UK. #Recoverytrial will be the 4th late-stage RCT evaluating REGN-COV2. Repurposed ➡️ Designed drugs https://t.co/mRq7gI571i

"Up to now, we have largely been studying whether existing drugs can be re-purposed to tackle this new disease, but we now have the opportunity to rigorously assess the impact of a drug specifically designed to target this coronavirus" @MartinLandray #Recoverytrial https://t.co/7TCo6fPxMD

The United States "could learn a lot from Britain" on COVID-19 research, including on the #RECOVERYtrial according to the New York Times @nytopinion @NottmBRCLung https://t.co/MyFqlgQee4

In Back to School interview Mark McClellan @DukeMargolis discusses #COVID19 and RECOVERY trials with @steveusdin1 View full interview & all Back to School content at: https://t.co/KDgSqdbzCF #RECOVERYtrial #FDA #DrugDevelopment #BCBacktoSchool #coronavirus https://t.co/y9NJbqX7LJ

RECOVERY appears to have done a bit better patient selection for tocilizumab than #COVACTA #EMPACTA , second randomization for progressive #COVID19 pt 👇, larger sample size, realistic data
Awaiting #Recoverytrial #IDTwitter #COVID19 https://t.co/JeW3Z8tLJG

RECOVERY appears to have done a bit better patient selection for tocilizumab than #COVACTA #EMPACTA , second randomization for progressive #COVID19 pt 👇, larger sample size, realistic data Awaiting #Recoverytrial #IDTwitter #COVID19 https://t.co/JeW3Z8tLJG

Quoted @MartinLandray

Excellent news: @EMA_News endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation based on the results of the #RECOVERYtrial https://t.co/ZQ7DHZkGJZ

#Covid19 tedavi : Avrupa Ilac Ajansi EMA #Recoverytrial klinik arastirmasi sonuclarina dayanarak oksijen destegi alan ya da yapay solunum cihazina baglanmis hastalarda #dexamethasone kullanimini onayladi.Eminiz @saglikbakanligi guncellenecek tedavi protokolunde bunu degerlendirir https://t.co/jOGUryNflJ

Excellent news: @EMA_News endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation based on the results of the #RECOVERYtrial https://t.co/ZQ7DHZkGJZ

@adarsh_bhimraj @JGPharmD @ABsteward @IDSAInfo @RMKGandhi @PaulSaxMD @ShohamTxID need to check GRADE assessment details. (Un)conscious biases here: -why is imbalance of interventions that don’t work (see sections in guide) a very serious limitation? Maybe someone in the panel believes in #HCQ, LPV? -open label design very serious here, not for #recoverytrial?

Monoclonal antibodies, which are potent, laboratory-made #antibodies, will be given to about 2K people to see if they are effective against #SARSCoV2. @BBCMorelle #RECOVERYtrial Coronavirus: Monoclonal antibodies to begin UK trial - BBC News https://t.co/sBkMYd6hht

NEWS: #RECOVERYTrial to evaluate @Regeneron's REGN-COV2 investigational antibody cocktail as a treatment for hospitalised patients with #COVID19 https://t.co/xjf78qFpby

Question If you have a #Covid_19 drug that has early intervention properties and had a 79% success rate in a placebo #COVID19 hospital trial, why would you back it ? #recoverytrial #prioritycovidresearch #coronavirus #CovidTesting #Covid19UK #COVID #Covid19usa #SNG001 #sng

Quoted @BBCNews

New antibody treatment to be trialled on coronavirus patients in UK hospitals https://t.co/4ccyKyvE1m

The #RECOVERYtrial - supported in Health Boards across Scotland - has announced the inclusion of a new investigational antiviral antibody treatment, REGN-COV2; the first specifically designed #COVID19 drug to be assessed through the flagship treatment trial. #research https://t.co/2Zn8SHKxLU

Quoted @MartinLandray

Coronavirus: Monoclonal antibodies to begin UK trial. Delighted that this new treatment, targeted specifically at the SARS-CoV-2 virus responsible for COVID-19, will now be studied in the #RECOVERYtrial. https://t.co/939vj3jvWB

Monoklonaaliset vasta-aineet todelliseen testiin #RECOVERYtrial:issa. Isot monikeskustutkimukset voivat riittävän nopeasti ja luotettavasti vastata potilaille tärkeisiin kysymyksiin #COVID-pandemiassa. Pieniä tutkimuksia ei kannata tehdä, kannattaa tehdä yhteistyötä ❤️ @mapetti https://t.co/x7x0BmZnf8

A summary and review of recent evidence for #steroids in ICU patients with #COVID19 & #ARDS, following the #recoverytrial, @remap_cap + others & @JAMA_current meta-analysis. https://t.co/PN3tpyXc71. Opinions own. @intensiveblog @AlfredIcu

Quoted @UKRI_News

ICYMI: A new monoclonal antibody treatment, developed by @Regeneron, will be added to the UKRI and @NIHRresearch-funded phase 3 RECOVERY trial to test its effectiveness in patients hospitalised with #COVID19. Read more: https://t.co/YF9M9DF480 https://t.co/kDKEaGwmcz

Hoping we don’t start to see increasing hospital admissions but it seems inevitable. At least we have an exciting addition of a new treatment added to the #Recoverytrial designed specifically to target #Covid_19 #BePartOfResearch https://t.co/uPNo6MBxyD

#Reuters dishonestly ignore scandal of retracted #Oxford #RecoveryTrial on #HCQ and report it as if @TheLancet & @NEJM had not withdrawn fraudulent research. Regeneron's antibody drug added to UK Recovery trial of COVID treatments | Article [AMP] | Reuters https://t.co/Ubj8S0OdLb

How #Surgisphere and #RecoveryTrial retracted papers demonising #Hydroxycholoroquine unravelled leading both studies to be withdrawn by @TheLancet and @NEJM. But despite the scandal UK MSM has barely covered the fraudulent figures and toxic doses. https://t.co/jqiMpUdHuA

Quoted @BBCMorelle

Special lab-made antibodies - called monoclonal antibodies - are to be given to #COVID19 patients in UK hospitals to see if the treatment works - it’s part of the huge Recovery Trial run by @UniofOxford #coronavirus https://t.co/TwfR2AFWN2

Coming up on #BBCNewsTen - #Covid19 patients in UK hospitals to be given monoclonal antibodies as part of #RECOVERYtrial to see if treatment is effective https://t.co/Y53xuzW3FV

Next Page